Cyclodextrins — Useful excipients for oral peptide administration?

https://doi.org/10.1016/0378-5173(96)04499-7Get rights and content

Abstract

Cyclodextrins have been investigated for their potential use as excipients for the oral delivery of peptides. A modified calcitonin and the somatostatin analog octapeptide octreotide (Sandostatin®) were chosen as model drugs. Both the potential of cyclodextrins for metabolic and physicochemical stabilization, as well as their use as absorption enhancers were evaluated in vitro using the Caco-2 cell monolayer model and in in situ absorption experiments with rats. Physical mixtures of the peptides with α-cyclodextrin, β-cyclodextrin, γ-cyclodextrin, hydroxypropyl-β-cyclodextrin and dimethyl-β-cyclodextrin were used throughout the experiments. The use of β-cyclodextrin and hydroxypropyl-β-cyclodextrin resulted in an increased chemical and enzymatic stability of the peptides. β-Cyclodextrin, γ-cyclodextrin and hydroxypropyl-β-cyclodextrin also showed absorption enhancing properties in the in vitro system as well as in the in situ study. No beneficial effects were observed for α-cyclodextrin. An enhanced permeation of the paracellular marker PEG-4000 across the cell monolayers in the presence of distinct cyclodextrins indicated an impairment of the tight junctional integrity as one reason for improved peptide absorption. The results suggest that distinct cyclodextrins have protective and absorption enhancing effects on peptides by preparing simple physical mixtures of the two components. However, the extent of protection and absorption enhancement seems to depend strongly on the nature of the peptide used as well as the chosen cyclodextrin.

Reference (12)

There are more references available in the full text version of this article.

Cited by (53)

  • Novel formulations and drug delivery systems to administer biological solids

    2021, Advanced Drug Delivery Reviews
    Citation Excerpt :

    Approaches that are commonly used in small-molecule development have been adapted to peptides to improve their solubility. These methods include the use of surfactants, polymer nanoparticles, solid lipid nanoparticles, microemulsions, liposomes, and micelles [154–161]. However, the most challenging obstacle for the oral delivery of peptides is attaining adequate systemic blood circulation levels due to (a) poor permeation across the intestine epithelial layer and (b) high first-pass clearance.

  • Approaches for enhancing oral bioavailability of peptides and proteins

    2013, International Journal of Pharmaceutics
    Citation Excerpt :

    Inclusion of peptides in β-cyclodextrin (β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-CD) cavity resulted in increased chemical and enzymatic stability of these peptides besides improving absorption. The reason for improved absorption may be due to impairment of tight junctional integrity which was observed through enhanced permeation of paracellular marker PEG-4000 (Haeberlin et al., 1996). Cyclodextrins have been shown to enhance chemical and physical stability of peptides and proteins through complexation.

  • Evaluation of protein stability and in vitro permeation of lyophilized polysaccharides-based microparticles for intranasal protein delivery

    2011, International Journal of Pharmaceutics
    Citation Excerpt :

    HP-β-CD has also been reported for stabilizing protein molecules in the pharmaceutical formulations (Brewster et al., 1991). The stabilizing effect of HP-β-CD is due to the fact that the aromatic phenylalanine, tyrosine and tryptophan residues of proteins could fit in the hydrophobic internal cavity of CD (Haeberlin et al., 1996). Moreover, it was also reported that sugars with HP-β-CD provide better stability in protein formulations than HP-β-CD alone (Iwai et al., 2007).

View all citing articles on Scopus
View full text